| Expenditures and prices of antihyperglycemic medications in the United States: 2002-2013 X Hua, N Carvalho, M Tew, ES Huang, WH Herman, P Clarke Jama 315 (13), 1400-1402, 2016 | 161 | 2016 |
| Computer modeling of diabetes and its transparency: a report on the eighth mount hood challenge AJ Palmer, L Si, M Tew, X Hua, MS Willis, C Asseburg, P McEwan, J Leal, ... Value in Health 21 (6), 724-731, 2018 | 79 | 2018 |
| Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs K Thursky, S Lingaratnam, J Jayarajan, GM Haeusler, B Teh, M Tew, ... BMJ open quality 7 (3), e000355, 2018 | 67 | 2018 |
| Growth of linked hospital data use in Australia: a systematic review M Tew, KM Dalziel, DJ Petrie, PM Clarke Australian Health Review 41 (4), 394-400, 2016 | 44 | 2016 |
| The challenge of transparency and validation in health economic decision modelling: a view from Mount Hood S Kent, F Becker, T Feenstra, A Tran-Duy, I Schlackow, M Tew, P Zhang, ... Pharmacoeconomics 37, 1305-1312, 2019 | 42 | 2019 |
| Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the ninth mount hood diabetes challenge L Si, MS Willis, C Asseburg, A Nilsson, M Tew, PM Clarke, M Lamotte, ... Value in Health 23 (9), 1163-1170, 2020 | 40 | 2020 |
| Patient-reported outcome measures (PROMs): can they be used to guide patient-centered care and optimize outcomes in total knee replacement? M Tew, K Dalziel, P Clarke, A Smith, PF Choong, M Dowsey Quality of Life Research 29, 3273-3283, 2020 | 34 | 2020 |
| [18F] FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial A Douglas, K Thursky, T Spelman, J Szer, A Bajel, S Harrison, SY Tio, ... The Lancet Haematology 9 (8), e573-e584, 2022 | 19 | 2022 |
| Associations between maternal size and health outcomes for women undergoing caesarean section: a multicentre prospective observational study (The MUM SIZE Study) AT Dennis, KE Lamb, D Story, M Tew, K Dalziel, P Clarke, J Lew, A Parker, ... BMJ open 7 (6), e015630, 2017 | 19 | 2017 |
| Quality of life in chronic limb threatening ischaemia: systematic review and meta-analysis LL Shan, LS Yang, M Tew, MJ Westcott, TD Spelman, PF Choong, ... European Journal of Vascular and Endovascular Surgery 64 (6), 666-683, 2022 | 13 | 2022 |
| Exploring structural uncertainty and impact of health state utility values on lifetime outcomes in diabetes economic simulation models: findings from the Ninth Mount Hood … M Tew, M Willis, C Asseburg, H Bennett, A Brennan, T Feenstra, J Gahn, ... Medical Decision Making 42 (5), 599-611, 2022 | 13 | 2022 |
| A Systematic review of cost-utility analyses in chronic limb-threatening ischemia LL Shan, J Wang, MJ Westcott, M Tew, AH Davies, PF Choong Annals of Vascular Surgery 85, 9-21, 2022 | 12 | 2022 |
| Incorporating future medical costs: impact on cost-effectiveness analysis in cancer patients M Tew, P Clarke, K Thursky, K Dalziel Pharmacoeconomics 37, 931-941, 2019 | 12 | 2019 |
| Excess cost of care associated with sepsis in cancer patients: results from a population-based case-control matched cohort M Tew, K Dalziel, K Thursky, M Krahn, L Abrahamyan, AM Morris, ... PLoS One 16 (8), e0255107, 2021 | 11 | 2021 |
| Measuring quality of life in chronic limb-threatening ischemia patients and informal carers: a scoping review LL Shan, MDY Shi, M Tew, MJ Westcott, AH Davies, PF Choong Annals of Surgery 276 (5), e331-e341, 2022 | 10 | 2022 |
| Cost‐effectiveness of home‐based care of febrile neutropenia in children with cancer M Tew, R De Abreu Lourenco, JR Gordon, KA Thursky, MA Slavin, ... Pediatric Blood & Cancer 69 (7), e29469, 2022 | 10 | 2022 |
| Co-morbidities and sex differences in long-term quality-of-life outcomes among patients with and without diabetes after total knee replacement: Five-year data from registry study M Tew, MM Dowsey, A Choong, PF Choong, P Clarke Journal of Clinical Medicine 9 (1), 19, 2019 | 10 | 2019 |
| Why is advance care planning underused in oncology settings? A systematic overview of reviews to identify the benefits, barriers, enablers, and interventions to improve uptake L Guccione, S Fullerton, K Gough, A Hyatt, M Tew, S Aranda, J Francis Frontiers in Oncology 13, 1040589, 2023 | 6 | 2023 |
| Site-specific factors associated with clinical trial recruitment efficiency in general practice settings: a comparative descriptive analysis M Tew, M Catchpool, J Furler, K De La Rue, P Clarke, ... Trials 24 (1), 164, 2023 | 5 | 2023 |
| National cost savings from an ambulatory program for low-risk febrile neutropenia patients in Australia M Tew, D Forster, BW Teh, K Dalziel Australian Health Review 43 (5), 549-555, 2019 | 4 | 2019 |
